The overall purpose of the observational, investigational pilot study is to assess the clinical utility of the Affect digital health platform (the Affect® "app") as part of the Affect program of treatment for methamphetamine-primary stimulant use disorder. The study also will identify elements of the Affect app that enhance engagement of participants in the study toward the goal of improving patient outcomes, including reduction/cessation of stimulant use.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Participant retention in treatment
Timeframe: Up to 8 weeks through the duration of treatment
Participant participation in program
Timeframe: Up to 8 weeks through the duration of treatment
Participant engagement with the Affect app
Timeframe: Up to 8 weeks through the duration of treatment
Participant satisfaction with the Affect app
Timeframe: Up to 8 weeks through the duration of treatment
Effectiveness in reducing meth use
Timeframe: Up to 8 weeks through the duration of treatment